Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000726186 | SCV000342722 | uncertain significance | not provided | 2016-07-15 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000726186 | SCV000620765 | uncertain significance | not provided | 2019-12-16 | criteria provided, single submitter | clinical testing | The majority of missense variants in this gene are considered pathogenic (Stenson et al., 2014); Has not been previously published as pathogenic or benign to our knowledge |
Labcorp Genetics |
RCV001274029 | SCV003253926 | uncertain significance | Glycogen storage disease, type V | 2022-07-03 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 3 of the PYGM protein (p.Arg3Gln). This variant is present in population databases (rs374812974, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with PYGM-related conditions. ClinVar contains an entry for this variant (Variation ID: 288565). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Revvity Omics, |
RCV001274029 | SCV003810420 | uncertain significance | Glycogen storage disease, type V | 2019-07-23 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000726186 | SCV005191339 | uncertain significance | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV001274029 | SCV001457734 | uncertain significance | Glycogen storage disease, type V | 2020-03-10 | no assertion criteria provided | clinical testing |